This week's report explores the pharmaceutical industry’s evolution toward resilient, scalable systems that prioritize ...
BabyCenter on MSN
RSV prevention in infants: What to know about the antibody treatment
The single-dose injection can help prevent RSV. Learn how it works and when your baby may be eligible.
As of Friday, January 23, Coherus Oncology, Inc.’s CHRS share price has surged by 21.70%, which has investors questioning if ...
Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of ...
Mindwalk identified TDP-43 antibodies that selectively target abnormal protein clumps linked to ALS and other diseases.
NICE has recommended obinutuzumab with mycophenolate for severe lupus nephritis after trials showed higher renal response and fewer flares.
Results from two clinical trials on ianalumab for Sjögren disease show favorable safety and adverse event outcomes, ...
ADC conjugation, redefined. Explore a rapid 3-hour workflow that delivers precise, controlled antibody-drug conjugates for ...
“Tecvayli Treatment Combo Improves Outcomes in Relapsed/Refractory Myeloma,” CURE; ...
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, announces the ...
GlaxoSmithKline (GSK) has agreed to acquire Rapt Therapeutics for $2.2 billion, the companies said today, in a deal intended to bolster the buyer’s pipeline with Rapt’s ozureprubart (RPT904), a ...
The prohibition halts support for projects both inside and outside the N.I.H. President Biden had restored funding after an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results